M N Hurley

Summary

Affiliation: University of Nottingham
Country: UK

Publications

  1. ncbi request reprint Rate of improvement of CF life expectancy exceeds that of general population-Observational death registration study
    Matthew N Hurley
    Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, E Floor East Block, Queens Medical Centre, Nottingham, NG7 2UH, United Kingdom Electronic address
    J Cyst Fibros 13:410-5. 2014
  2. doi request reprint Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
    Matthew N Hurley
    Department of Child Health, School of Clinical Sciences, University of Nottingham, Nottingham, UK
    Cochrane Database Syst Rev 6:CD008037. 2013
  3. pmc Fluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosis
    Matthew Hurley
    Division of Child Health, University of Nottingham, Queens Medical Centre, Nottingham, UK
    Ther Adv Respir Dis 6:363-73. 2012
  4. pmc Delayed publication of clinical trials in cystic fibrosis
    M N Hurley
    Division of Child Health, School of Clinical Sciences, University of Nottingham, Nottingham, NG7 2UH, UK
    J Cyst Fibros 11:14-7. 2012
  5. pmc Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
    Matthew N Hurley
    Dept of Child Health, University of Nottingham, E Floor, East Block, Queens Medical Centre, Nottingham, NG7 2UHUK
    Eur Respir J 40:1014-23. 2012
  6. pmc Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
    M N Hurley
    Division of Child Health, School of Clinical Sciences, University of Nottingham, Nottingham, NG7 2UH, UK
    J Cyst Fibros 11:288-92. 2012

Detail Information

Publications6

  1. ncbi request reprint Rate of improvement of CF life expectancy exceeds that of general population-Observational death registration study
    Matthew N Hurley
    Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, E Floor East Block, Queens Medical Centre, Nottingham, NG7 2UH, United Kingdom Electronic address
    J Cyst Fibros 13:410-5. 2014
    ..It is unclear why cystic fibrosis (CF) survival has improved. We wished to quantify increases in CF median age of death in the context of general population survival improvement...
  2. doi request reprint Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
    Matthew N Hurley
    Department of Child Health, School of Clinical Sciences, University of Nottingham, Nottingham, UK
    Cochrane Database Syst Rev 6:CD008037. 2013
    ..Antibiotic adjuvants - therapies that act by rendering the organism more susceptible to attack by antibiotics or the host immune system, by rendering it less virulent or killing it by other means, are urgently needed...
  3. pmc Fluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosis
    Matthew Hurley
    Division of Child Health, University of Nottingham, Queens Medical Centre, Nottingham, UK
    Ther Adv Respir Dis 6:363-73. 2012
    ..The safety of fluoroquinolones and the use of newer agents in the class are also discussed...
  4. pmc Delayed publication of clinical trials in cystic fibrosis
    M N Hurley
    Division of Child Health, School of Clinical Sciences, University of Nottingham, Nottingham, NG7 2UH, UK
    J Cyst Fibros 11:14-7. 2012
    ..Clinical trial registries allow researchers to interrogate the trial protocol and afford the opportunity to identify studies that have been completed and so determine the time lag between completion and publication...
  5. pmc Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
    Matthew N Hurley
    Dept of Child Health, University of Nottingham, E Floor, East Block, Queens Medical Centre, Nottingham, NG7 2UHUK
    Eur Respir J 40:1014-23. 2012
    ..Both therapeutic approaches in early development and clinical phase are discussed...
  6. pmc Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
    M N Hurley
    Division of Child Health, School of Clinical Sciences, University of Nottingham, Nottingham, NG7 2UH, UK
    J Cyst Fibros 11:288-92. 2012
    ..Patients with CF experience pulmonary exacerbations. These are often initially empirically treated with intravenous antibiotics, with antibiotic choice refined after susceptibility testing...